What type of protection is best in Europe?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Vossius, V. 1982. Banbury Report 10, 149; Vossius, V., and Jaenichen, H.-R. In press. Banbury Report 36; Vossius, V. 1992. European Intellectual Property Reviews 11, 412.
T32/82 “Control circuit/ICI,” OJ EPO 1984, 354.
970 F.2d 834, 23 USPQ2d 1481 (Fed.Cir. 1992).
In re Durden, 763 F. 2d 1406, 1409-10 (Fed. Cir. 1985).
Wegner, H.C., 1992. Patent Law in Biotechnology, Chemicals and Pharmaceutical, New York: Stockton Press, § 275.
T119/82 “Gelation/Exxon,” OJ EPO 1984, 217.
T36/83 “Thenoylperoxide/ROUSSEL-UCLAF,” OJ EPO 1986, 295; T128/82 “Pyrrolidine-derivatives/HOFFMANN-LA ROCHE,” OJ EPO 1984, 164.
For example, Gr05/83 “Second medical indication/EISAI,” OJ EPO 1985,64; T290/86 “Cleaning plaque/ICI,” OJ EPO 1992,414.
G2/88 “Friction reducing additive/MOBIL OIL III,” OJ EPO 1990, 93; G6/88 “Plant growth regulating agent/BAYER,” OJ EPO 1990, 114.
“Onco-mouse/HARVARD,” OJ EPO 1992, 588; Decisions of the opposition division in Lubrizol's European patent 122 791 of June 5, 1992 (not published) and in Plant Genetic Systems N.V. European patent 242 236 of December 15, 1992 (not published).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vossius, V., Lacroix, S. & Dörries, U. Product, Product-by-Process, Process and Use. Nat Biotechnol 11, 1174–1176 (1993). https://doi.org/10.1038/nbt1093-1174
Issue Date:
DOI: https://doi.org/10.1038/nbt1093-1174